Dr. Reddy's Drops Patent Challenge To Glaxo's Zofran
As a result, Dr. Reddy's will not attempt to launch a cheap generic version of the product in the U.S. until after the compound patent expires in July 2005.
Glaxo also has two "method-of-use" patents expiring in 2005 and 2006.
GlaxoSmithKline had filed a lawsuit against Dr Reddy's Laboratories Ltd in the U.S.District Court for the district of...
To view the full article, register now.